CHIH LIN, PhD

Dr. Wu is the Chairman of Taiwan BIO since 2020 while he has been the President of Development Center for Biotechnology since 2018. He is an entrepreneur and an expert in biologics, including recombinant proteins, vaccines, and therapeutic antibodies. He was an associate professor of the Institute of Molecular Medicine, National Taiwan University in 1995 - 2000. In 2000, he co-founded AbGenomics Corp., a biotech company specialized in developing therapeutic antibodies. Over the past 20 years, he produced over 30 publications in peer-reviewed scientific journals and 8 international patents, of which all were licensed-out for commercial applica¬tion. Dr. Wu received his Ph.D. from University of Maryland and was a Jane-Coffin-Childs Memorial Fund Fellow in the Department of Embryology, Carnegie Institution of Washington.